Redcare Pharmacy NV (CHIX:RDCd)
€ 51.58 (0%) Market Cap: 1.43 Bil Enterprise Value: 1.69 Bil PE Ratio: 0 PB Ratio: 3.13 GF Score: 65/100

Half Year 2026 Redcare Pharmacy NV Earnings Call Transcript

Jul 29, 2026 / 08:00 AM GMT
Release Date Price: €51.58

Key Points

Positve
  • Redcare Pharmacy NV (SHPPF) increased its 2026 revenue growth guidance to 15% to 17%, up from the previous 13% to 15%.
  • The company reported a significant increase in RX active customers in Germany, reaching 1.7 million, a 4% growth quarter over quarter.
  • Adjusted EBITDA margin improved to 3.5% in Q2, marking the highest level in 10 years.
  • The company has successfully reduced marketing spending while maintaining high growth, indicating efficient cost management.
  • Redcare Pharmacy NV (SHPPF) has achieved a decade of double-digit growth, with a significant expansion of its active customer base since its IPO.
Negative
  • The German non-RX business experienced some deceleration in growth, partly attributed to a heatwave and competitive market conditions.
  • The introduction of a personal signature requirement for prescription deliveries may slightly increase last-mile delivery costs.
  • July trading was softer, with expected group growth below 20%, indicating potential challenges in maintaining high growth rates.
  • The company faces challenges in accelerating new customer acquisition, particularly in changing customer behavior and adoption.
  • Despite increased profitability, the company was not cash flow positive in Q2, highlighting ongoing challenges in cash cycle management.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RDC.DE - Redcare Pharmacy NV
Half Year 2026 Redcare Pharmacy NV Earnings Call
Jul 29, 2026 / 08:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
To Olaf Heinrich, CEO, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yes, thank you very much and good morning to everybody and very warm welcome from our side.

Let's have a look at the agenda of today. So first of all, we would like to start with a recap, then a business update, afterwards financial updates, and then we have plenty of time for a Q&A session.

So if we go to the next slide, let's start with an update from the guidance. As we increased our 2026 guidance for revenue growth and profitability back in June. And I want to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot